Carbon monoxide: present and future indications for a medical gas

키워드

참고문헌 (170)

1. Gentile MA., "Inhaled medical gases: more to breathe than oxygen", Respir Care, 56, pp.1341~1357 (2011)
2. Kashiba M, "From O2 to H2S: a landscape view of gas biology", Keio J Med, 51, pp.1~10 (2002)
3. Nakao A, "Therapeutic antioxidant medical gas", J Clin Biochem Nutr, 44, pp.1~13 (2009)
4. Bloch KD, "Inhaled NO as a therapeutic agent", Cardiovasc Res, 75, pp.339~348 (2007)
5. Ryter SW, "Gaseous therapeutics in acute lung injury", Compr Physiol, 1, pp.105~121 (2011)
6. Ryter SW, "Heme oxygenase-1", carbon monoxide: from metabolism to molecular therapy, 2009, pp.41, 251~260
7. Ryter SW, "Heme oxygenase-1", carbon monoxide: from basic science to therapeutic applications, 2006, pp.86, 583~650
8. Ryter SW, "Carbon monoxide: to boldly go where NO has gone before", Sci STKE, 2004, pp.6~ (2004)
9. Wu L, "Carbon monoxide: endogenous production, physiological functions, and pharmacological applications", Pharmacol Rev, 57, pp.585~630 (2005)
10. Ryter SW, "Carbon monoxide in biology and medicine", Bioessays, 26, pp.270~280 (2004)
11. Motterlini R, "The therapeutic potential of carbon monoxide", Nat Rev Drug Discov, 9, pp.728~743 (2010)
12. Kashfi K, "Biology and therapeutic potential of hydrogen sulfide and hydrogen sulfide-releasing chimeras", Biochem Pharmacol, 85, pp.689~703 (2013)
13. Wagner F, "Bench-to-bedside review: hydrogen sulfide: the third gaseous transmitter: applications for critical care", Crit Care, 13, pp.213~ (2009)
14. Liu YH, "Bian JS. Hydrogen sulf ide: a novel signaling molecule in the vascular system", J Cardiovasc Pharmacol, 58, pp.560~569 (2011)
15. Wang R., "Two’s company, three’s a crowd: can H2S be the third endogenous gaseous transmitter?", FASEB J, 16, pp.1792~1798 (2002)
16. Moody BF, "Emergent role of gasotransmitters in ischemia-reperfusion injury", Med Gas Res, 1, pp.3~ (2011)
17. Wink DA, "Chemical biology of nitric oxide: insights into regulatory, cytotoxic, and cytoprotective mechanisms of nitric oxide", Free Radic Biol Med, 25, pp.434~456 (1998)
18. Tenhunen R, "The enzymatic conversion of heme to bilirubin by microsomal heme oxygenase", Proc Natl Acad Sci U S A, 61, pp.748~755 (1968)
19. Tenhunen R, "Microsomal heme oxygenase: characterization of the enzyme", J Biol Chem, 244, pp.6388~6394 (1969)
20. Keyse SM, "Heme oxygenase is the major 32- kDa stress protein induced in human skin fibroblasts by UVA radiation, hydrogen peroxide, and sodium arsenite", Proc Natl Acad Sci U S A, 86, pp.99~103 (1989)
21. Maines MD., "The heme oxygenase system: a regulator of second messenger gases", Annu Rev Pharmacol Toxicol, 37, pp.517~554 (1997)
22. Maines MD, "Characterization of two constitutive forms of rat liver microsomal heme oxygenase: only one molecular species of the enzyme is inducible", J Biol Chem, 261, pp.411~419 (1986)
23. Vandiver M, "Hydrogen sulf ide: a gasotransmitter of clinical relevance", J Mol Med, 90, pp.255~263 (2012)
24. Ignarro LJ, "Endothelium-derived relaxing factor produced and released from artery and vein is nitric oxide", Proc Natl Acad Sci U S A, 84, pp.9265~9269 (1987)
25. Ignarro LJ, "Endothelium- derived relaxing factor from pulmonary artery and vein possesses pharmacologic and chemical properties identical to those of nitric oxide radical", Circ Res, 61, pp.866~879 (1987)
26. Moncada S, "Nitric oxide: physiology, pathophysiology, and pharmacology", Pharmacol Rev, 43, pp.109~142 (1991)
27. Ignarro LJ., "Nitric oxide: a unique endogenous signaling molecule in vascular biology", Biosci Rep, 19, pp.51~71 (1999)
28. Snyder SH, "Biological roles of nitric oxide", Sci Am, 266, pp.68~77 (1992)
29. Derbyshire ER, "Structure and regulation of soluble guanylate cyclase", Annu Rev Biochem, 81, pp.533~559 (2012)
30. Ichinose F, "Inhaled nitric oxide: a selective pulmonary vasodilator: current uses and therapeutic potential", Circulation, 109, pp.3106~3111 (2004)
31. Frostell C, "Inhaled nitric oxide: a selective pulmonary vasodilator reversing hypoxic pulmonary vasoconstriction", Circulation, 83, pp.2038~2047 (1991)
32. Rossaint R, "Inhaled nitric oxide for the adult respiratory distress syndrome", N Engl J Med, 328, pp.399~405 (1993)
33. Porta NF, "Pulmonary vasodilator therapy in the NICU: inhaled nitric oxide, sildenafil, and other pulmonary vasodilating agents", Clin Perinatol, 39, pp.149~164 (2012)
34. Hartsf ield CL., "Cross talk between carbon monoxide and nitric oxide", Antioxid Redox Signal, 4, pp.301~307 (2002)
35. Piantadosi CA., "Biological chemistry of carbon monoxide", Antioxid Redox Signal, 4, pp.259~270 (2002)
36. Sjostrand T., "The formation of carbon monoxide by the decomposition of haemoglobin in vivo", Acta Physiol Scand, 26, pp.338~344 (1952)
37. Sjostrand T., "Endogenous production of carbon monoxide in man under normal and pathophysiological conditions", Scand J Clin Lab Invest, 1, pp.201~214 (1949)
38. Coburn RF, "Endogenous carbon monoxide production in man", J Clin Invest, 42, pp.1172~1178 (1963)
39. Tenhunen R, "The enzymatic catabolism of hemoglobin: stimulation of microsomal heme oxygenase by hemin", J Lab Clin Med, 75, pp.410~421 (1970)
40. Kageyama H, "Isolation and characterization of a complementary DNA clone for a Mr 32,000 protein which is induced with tumor promoters in BALB", c 3T3 cells, 1988, pp.48, 4795~4798
41. Keyse SM, "Both near ultraviolet radiation and the oxidizing agent hydrogen peroxide induce a 32- kDa stress protein in normal human skin fibroblasts", J Biol Chem, 262, pp.14821~14825 (1987)
42. Applegate LA, "Induction of heme oxygenase: a general response to oxidant stress in cultured mammalian cells", Cancer Res, 51, pp.974~978 (1991)
43. Otterbein LE, "Carbon monoxide has anti-inf lammatory effects involving the mitogenactivated protein kinase pathway", Nat Med, 6, pp.422~428 (2000)
44. Verma A, "Carbon monoxide: a putative neural messenger", Science, 259, pp.381~384 (1993)
45. Brouard S, "Carbon monoxide generated by heme oxygenase 1 suppresses endothelial cell apoptosis", J Exp Med, 192, pp.1015~1026 (2000)
46. Kim HP, "CO as a cellular signaling molecule", Annu Rev Pharmacol Toxicol, 46, pp.411~449 (2006)
47. Durante W, "Role of carbon monoxide in cardiovascular function", J Cell Mol Med, 10, pp.672~686 (2006)
48. Suematsu M, "Carbon monoxide as an endogenous modulator of hepatic vascular perfusion", Biochem Biophys Res Commun, 205, pp.1333~1337 (1994)
49. Morita T, "Carbon monoxide controls the proliferation of hypoxic vascular smooth muscle cells", J Biol Chem, 272, pp.32804~32809 (1997)
50. Suliman HB, "A new activating role for CO in cardiac mitochondrial biogenesis", J Cell Sci, 120, pp.299~308 (2007)
51. Lee SJ, "Carbon monoxide activates autophagy via mitochondrial reactive oxygen species formation", Am J Respir Cell Mol Biol, 45, pp.867~873 (2011)
52. Otterbein LE, "Carbon monoxide provides protection against hyperoxic lung injury", Am J Physiol, 276(4), pp.688~694 (1999)
53. Otterbein LE, "MKK3 mitogen-activated protein kinase pathway mediates carbon monoxide-induced protection against oxidantinduced lung injury", Am J Pathol, 163, pp.2555~2563 (2003)
54. Dolinay T, "Inhaled carbon monoxide confers antiinf lammatory effects against ventilator-induced lung injury", Am J Respir Crit Care Med, 170, pp.613~620 (2004)
55. Zhang X, "Carbon monoxide modulates Fas", Fas ligand, caspases, and Bcl-2 family proteins via the p38alpha mitogenactivated protein kinase pathway during ischemiareperfusion lung injury, 2003, pp.278, 22061~22070
56. Zhang X, "Carbon monoxide inhibition of apoptosis during ischemia-reperfusion lung injury is dependent on the p38 mitogen-activated protein kinase pathway and involves caspase 3", J Biol Chem, 278, pp.1248~1258 (2003)
57. MacGarvey NC, "Activation of mitochondrial biogenesis by heme oxygenase-1- mediated NF-E2-related factor-2 induction rescues mice from lethal Staphylococcus aureus sepsis", Am J Respir Crit Care Med, 185, pp.851~861 (2012)
58. Otterbein LE, "Carbon monoxide suppresses arteriosclerotic lesions associated with chronic graft rejection and with balloon injury", Nat Med, 9, pp.183~190 (2003)
59. Sato K, "Carbon monoxide generated by heme oxygenase-1 suppresses the rejection of mouse-to-rat cardiac transplants", J Immunol, 166, pp.4185~4194 (2001)
60. Song R, "Carbon monoxide induces cytoprotection in rat orthotopic lung transplantation via anti-inf lammatory and anti-apoptotic effects", Am J Pathol, 163, pp.231~242 (2003)
61. Ryter SW, "Heme oxygenase-1", carbon monoxide: novel therapeutic strategies in critical care medicine, 2010, pp.11, 1485~1494
62. Whiteman M, "Whatmore J. Emerging role of hydrogen sulfide in health and disease: critical appraisal of biomarkers and pharmacological tools", Clin Sci, 121, pp.459~488 (2011)
63. Yang G, "H2S as a physiologic vasorelaxant: hypertension in mice with deletion of cystathionine gamma-lyase", Science, 322, pp.587~590 (2008)
64. Kimura H., "Hydrogen sulfide as a neuromodulator", Mol Neurobiol, 26, pp.13~19 (2002)
65. Szabo C., "Hydrogen sulphide and its therapeutic potential", Nat Rev Drug Discov, 6, pp.917~935 (2007)
66. Lowicka E, "Hydrogen sulf ide (H2S): the third gas of interest for pharmacologists", Pharmacol Rep, 59, pp.4~24 (2007)
67. Faller S, "Hydrogen sulfide prevents hyperoxia-induced lung injury by downregulating reactive oxygen species formation and angiopoietin-2 release", Curr Pharm Des (2012)
68. Faller S, "Inhaled hydrogen sulfide protects against ventilator- induced lung injury", Anesthesiology, 113, pp.104~115 (2010)
69. Spiller F, "Hydrogen sulfide improves neutrophil migration and survival in sepsis via K+ATP channel activation", Am J Respir Crit Care Med, 182, pp.360~368 (2010)
70. Von Burg R., "Ca rbon monox ide", J Appl Tox icol, 19, pp.379~386 (1999)
71. Penney D, "Carbon monoxide, In WHO Guidelines for Indoor Air Quality: Selected Pollutants", pp.55~ (2010), WHO
72. Raub J., "Environmental Health Criteria 213, In Carbon Monoxide Second Edition", pp.70~ (1999), WHO
73. Smith RP., "Toxic responses of the blood, In Casarett and Doull’s Toxicology: the Basic Science of Poisons. 3rd ed", pp.223~224 (1986), Macmillan
74. Gorman D, "The clinical toxicology of carbon monoxide", Toxicology, 187, pp.25~38 (2003)
75. Piantadosi CA, "Diagnosis and treatment of carbon monoxide poisoning", Respir Care Clin N Am, 5, pp.183~202 (1999)
76. Rudra CB, "Relation of whole blood carboxyhemoglobin concentration to ambient carbon monoxide exposure estimated using regression", Am J Epidemiol, 171, pp.942~951 (2010)
77. Russell MA., "Blood carboxyhaemoglobin changes during tobacco smoking", Postgrad Med J, 49, pp.684~687 (1973)
78. Samoli E, "Short-term effects of carbon monoxide on mortality: an analysis within the APHEA project", Environ Health Perspect, 115, pp.1578~1583 (2007)
79. Reboul C, "Carbon monoxide exposure in the urban environment: an insidious foe for the heart?", Respir Physiol Neurobiol, 184, pp.204~212 (2012)
80. Kutty RK, "Rat liver cytochrome P-450b, P-420b, and P-420c are degraded to biliverdin by heme oxygenase", Arch Biochem Biophys, 260, pp.638~644 (1988)
81. Tenhunen R, "Reduced nicotinamide-adenine dinucleotide phosphate dependent biliverdin reductase: partial purification and characterization", Biochemistry, 9, pp.298~303 (1970)
82. Vreman HJ, "Carbon monoxide in breath, blood, and other tissues, In Carbon Monoxide Toxicity", pp.19~60 (2000), CRC Press
83. Cruse I, "Evidence suggesting that the two forms of heme oxygenase are products of different genes", J Biol Chem, 263, pp.3348~3353 (1988)
84. Lee PJ, "Hypoxia-inducible factor- 1 mediates transcriptional activation of the heme oxygenase-1 gene in response to hypoxia", J Biol Chem, 272, pp.5375~5381 (1997)
85. Lee PJ, "Regulation of heme oxygenase-1 expression in vivo and in vitro in hyperoxic lung injury", Am J Respir Cell Mol Biol, 14, pp.556~568 (1996)
86. Shibahara S, "Transcriptional control of rat heme oxygenase by heat shock", J Biol Chem, 262, pp.12889~12892 (1987)
87. Alam J, "Transcriptional activation of the heme oxygenase gene by heme and cadmium in mouse hepatoma cells", J Biol Chem, 264, pp.6371~6375 (1989)
88. Keyse SM, "Oxidant stress leads to transcriptional activation of the human heme oxygenase gene in cultured skin fibroblasts", Mol Cell Biol, 10, pp.4967~4969 (1990)
89. Alam J, "Isolation and characterization of the mouse heme oxygenase-1 gene: distal 5’ sequences are required for induction by heme or heavy metals", J Biol Chem, 269, pp.1001~1009 (1994)
90. Alam J, "Identification of a second region upstream of the mouse heme oxygenase-1 gene that functions as a basal level and inducer-dependent transcription enhancer", J Biol Chem, 270, pp.11977~11984 (1995)
91. Alam J, "Nrf2, a Cap’n’Collar transcription factor, regulates induction of the heme oxygenase-1 gene", J Biol Chem, 274, pp.26071~26078 (1999)
92. Alam J, "Mechanism of heme oxygenase-1 gene activation by cadmium in MCF-7 mammary epithelial cells: role of p38 kinase and Nrf2 transcription factor", J Biol Chem, 275, pp.27694~27702 (2000)
93. Itoh K, "Keap1 represses nuclear activation of antioxidant responsive elements by Nrf2 through binding to the amino-terminal Neh2 domain", Genes Dev, 13, pp.76~86 (1999)
94. Kobayashi A, "Oxidative stress sensor Keap1 functions as an adaptor for Cul3-based E3 ligase to regulate proteasomal degradation of Nrf2", Mol Cell Biol, 24, pp.7130~7139 (2004)
95. Ogawa K, "Heme mediates derepression of Maf recognition element through direct binding to transcription repressor Bach1", EMBO J, 20, pp.2835~2843 (2001)
96. Sun J, "Hemoprotein Bach1 regulates enhancer availability of heme oxygenase-1 gene", EMBO J, 21, pp.5216~5224 (2002)
97. Alam J, "Regulation of heme oxygenase-1 gene transcription: recent advances and highlights from the International Conference (Uppsala, 2003) on Heme Oxygenase", Antioxid Redox Signal, 6, pp.924~933 (2004)
98. Alam J, "How many transcription factors does it take to turn on the heme oxygenase-1 gene?", Am J Respir Cell Mol Biol, 36, pp.166~174 (2007)
99. Stone JR, "Soluble guanylate cyclase from bovine lung: activation with nitric oxide and carbon monoxide and spectral characterization of the ferrous and ferric states", Biochemistry, 33, pp.5636~5640 (1994)
100. Furchgott RF, "Endothelium-dependent and -independent vasodilation involving cyclic GMP: relaxation induced by nitric oxide, carbon monoxide and light", Blood Vessels, 28, pp.52~61 (1991)
101. Suematsu M, "Carbon monoxide: an endogenous modulator of sinusoidal tone in the perfused rat liver", J Clin Invest, 96, pp.2431~2437 (1995)
102. Wang R., "Resurgence of carbon monoxide: an endogenous gaseous vasorelaxing factor", Can J Physiol Pharmacol, 76, pp.1~15 (1998)
103. Nakahira K, "Carbon monoxide differentially inhibits TLR signaling pathways by regulating ROS-induced trafficking of TLRs to lipid rafts", J Exp Med, 203, pp.2377~2389 (2006)
104. Kim HP, "Heat shock protein-70 mediates the cytoprotective effect of carbon monoxide: involvement of p38 beta MAPK and heat shock factor-1", J Immunol, 175, pp.2622~2629 (2005)
105. Bilban M, "Carbon monoxide orchestrates a protective response through PPARgamma", Immunity, 24, pp.601~610 (2006)
106. Brouard S, "Heme oxygenase-1-derived carbon monoxide requires the activation of transcription factor NF-kappa B to protect endothelial cells from tumor necrosis factor-alpha-mediated apoptosis", J Biol Chem, 277, pp.17950~17961 (2002)
107. Zhang X, "Carbon monoxide differentially modulates STAT1 and STAT3 and inhibits apoptosis via a phosphatidylinositol 3-kinase", Akt and p38 kinase-dependent STAT3 pathway during anoxia- reoxygenation injury, 2005, pp.280, 8714~8721
108. Wang X, "Carbon monoxide protects against hyperoxia-induced endothelial cell apoptosis by inhibiting reactive oxygen species formation", J Biol Chem, 282, pp.1718~1726 (2007)
109. Wang X, "Carbon monoxide inhibits Fas activating antibodyinduced apoptosis in endothelial cells", Med Gas Res, 1, pp.8~ (2011)
110. Morita T, "Smooth muscle cell-derived carbon monoxide is a regulator of vascular cGMP", Proc Natl Acad Sci U S A, 92, pp.1475~1479 (1995)
111. Morita T, "Endothelial cell expression of vasoconstrictors and growth factors is regulated by smooth muscle cell-derived carbon monoxide", J Clin Invest, 96, pp.2676~2682 (1995)
112. Kim HP, "Caveolin-1 expression by means of p38beta mitogen-activated protein kinase mediates the antiproliferative effect of carbon monoxide", Proc Natl Acad Sci U S A, 102, pp.11319~11324 (2005)
113. Taille C, "Mitochondrial respiratory chain and NAD(P)H oxidase are targets for the antiproliferative effect of carbon monoxide in human airway smooth muscle", J Biol Chem, 280, pp.25350~25360 (2005)
114. Rodriguez AI, "HO-1 and CO decrease platelet-derived growth factor-induced vascular smooth muscle cell migration via inhibition of Nox1", Arterioscler Thromb Vasc Biol, 30, pp.98~104 (2010)
115. Morse D, "Suppression of inf lammatory cytokine production by carbon monoxide involves the JNK pathway and AP-1", J Biol Chem, 278, pp.36993~36998 (2003)
116. Mazzola S, "Carbon monoxide pretreatment prevents respiratory derangement and ameliorates hyperacute endotoxic shock in pigs", FASEB J, 19, pp.2045~2047 (2005)
117. Mitchell LA, "Evaluation of inhaled carbon monoxide as an anti-inflammatory therapy in a nonhuman primate model of lung inf lammation", Am J Physiol Lung Cell Mol Physiol, 299, pp.891~897 (2010)
118. Ghosh S, "Effects of inhaled carbon monoxide on acute lung injury in mice", Am J Physiol Lung Cell Mol Physiol, 288, pp.1003~1009 (2005)
119. Clayton CE, "Inhaled carbon monoxide and hyperoxic lung injury in rats", Am J Physiol Lung Cell Mol Physiol, 281, pp.949~957 (2001)
120. Fernandez-Gonzalez A, "Vasculoprotective effects of heme oxygenase-1 in a murine model of hyperoxia-induced bronchopulmonary dysplasia", Am J Physiol Lung Cell Mol Physiol, 302, pp.775~784 (2012)
121. Hoetzel A, "Carbon monoxide prevents ventilator-induced lung injury via caveolin", Crit Care Med, 37, pp.1708~1715 (2009)
122. Hoetzel A, "Carbon monoxide protects against ventilator-induced lung injury via PPAR-gamma and inhibition of Egr-1", Am J Respir Crit Care Med, 177, pp.1223~1232 (2008)
123. Faller S, "Kinetic effects of carbon monoxide inhalation on tissue protection in ventilator-induced lung injury", Lab Invest, 92, pp.999~1012 (2012)
124. Fujita T, "Paradoxical rescue from ischemic lung injury by inhaled carbon monoxide driven by derepression of fibrinolysis", Nat Med, 7, pp.598~604 (2001)
125. Mishra S, "Carbon monoxide rescues ischemic lungs by interrupting MAPKdriven expression of early growth response 1 gene and its downstream target genes", Proc Natl Acad Sci U S A, 103, pp.5191~5196 (2006)
126. Schallner N, "Postconditioning with inhaled carbon monoxide counteracts apoptosis and neuroinflammation in the ischemic rat retina", PLoS One, 7, pp.46479~ (2012)
127. Nakao A, "Protective effect of carbon monoxide inhalation for cold-preserved small intestinal grafts", Surgery, 134, pp.285~292 (2003)
128. Faleo G, "Carbon monoxide ameliorates renal cold ischemia-reperfusion injury with an upregulation of vascular endothelial growth factor by activation of hypoxia-inducible factor", Transplantation, 85, pp.1833~1840 (2008)
129. Kaizu T, "Carbon monoxide inhalation ameliorates cold ischemia", reperfusion injury after rat liver transplantation, 2005, pp.138, 229~235
130. Kohmoto J, "Low-dose carbon monoxide inhalation prevents ischemia", reperfusion injury of transplanted rat lung grafts, 2006, pp.140, 179~185
131. Kohmoto J, "Carbon monoxide- saturated preservation solution protects lung grafts from ischemia-reperfusion injury", J Thorac Cardiovasc Surg, 136, pp.1067~1075 (2003)
132. Nakao A, "Ex vivo application of carbon monoxide in University of Wisconsin solution to prevent intestinal cold ischemia", reperfusion injury, 2006, pp.6, 2243~2255
133. Pannen BH, "Protective role of endogenous carbon monoxide in hepatic microcirculatory dysfunction after hemorrhagic shock in rats", J Clin Invest, 102, pp.1220~1228 (1998)
134. Amersi F, "Ex vivo exposure to carbon monoxide prevents hepatic ischemia", reperfusion injury through p38 MAP kinase pathway, 2002, pp.35, 815~823
135. Christou H, "Prevention of hypoxia-induced pulmonary hypertension by enhancement of endogenous heme oxygenase-1 in the rat", Circ Res, 86, pp.1224~1229 (2000)
136. Minamino T, "Targeted expression of heme oxygenase-1 prevents the pulmonary inflammatory and vascular responses to hypoxia", Proc Natl Acad Sci U S A, 98, pp.8798~8803 (2001)
137. Yet SF, "Hypoxia induces severe right ventricular dilatation and infarction in heme oxygenase-1 null mice", J Clin Invest, 103, pp.23~29 (1999)
138. Zuckerbraun BS, "Carbon monoxide reverses established pulmonary hypertension", J Exp Med, 203, pp.2109~2119 (2006)
139. Dubuis E, "Continuous inhalation of carbon monoxide attenuates hypoxic pulmonary hypertension development presumably through activation of BKCa channels", Cardiovasc Res, 65, pp.751~761 (2005)
140. Selman M, "American Thoracic Society; European Respiratory Society; American College of Chest Physicians. Idiopathic pulmonary f ibrosis: prevailing and evolving hypotheses about its pathogenesis and implications for therapy", Ann Intern Med, 134, pp.136~151 (2001)
141. Zhou Z, "Carbon monoxide suppresses bleomycin-induced lung f ibrosis", Am J Pathol, 166, pp.27~37 (2005)
142. Choi KM, "Heme oxygenase- 1 protects interstitial cells of Cajal from oxidative stress and reverses diabetic gastroparesis", Gastroenterology, 135, pp.2055~2064 (2008)
143. Kashyap PC, "Carbon monoxide reverses diabetic gastroparesis in NOD mice", Am J Physiol Gastrointest Liver Physiol, 298, pp.1013~1019 (2010)
144. Rodella L, "Carbon monoxide and biliverdin prevent endothelial cell sloughing in rats with type I diabetes", Free Radic Biol Med, 40, pp.2198~2205 (2006)
145. Simon T, "Carbon monoxidetreated dendritic cells decrease beta1-integrin induction on CD8(+) T cells and protect from type 1 diabetes", Eur J Immunol, 43, pp.209~218 (2013)
146. Gunther L, "Carbon monoxide protects pancreatic beta-cells from apoptosis and improves islet function", survival after transplantation, 2002, pp.51, 994~999
147. Wang H, "Donor treatment with carbon monoxide can yield islet allograft survival and tolerance", Diabetes, 54, pp.1400~1406 (2005)
148. Joe Y, "The role of carbon monoxide in metabolic disease", Ann N Y Acad Sci, 1229, pp.156~161 (2011)
149. Lancel S, "Carbon monoxide improves cardiac function and mitochondrial population quality in a mouse model of metabolic syndrome", PLoS One, 7, pp.41836~ (2012)
150. Bainbridge SA, "Direct placental effects of cigarette smoke protect women from preeclampsia: the specific roles of carbon monoxide and antioxidant systems in the placenta", Med Hypotheses, 64, pp.17~27 (2005)
151. Ahmed A, "Induction of placental heme oxygenase-1 is protective against TNFalpha- induced cytotoxicity and promotes vessel relaxation", Mol Med, 6, pp.391~409 (2000)
152. Yusuf K, "Carboxyhemoglobin levels in umbilical cord blood of women with pre-eclampsia and intrauterine growth restriction", J Perinat Med (2012)
153. Bainbridge SA, "Carbon monoxide inhibits hypoxia", reoxygenation- induced apoptosis and secondary necrosis in syncytiotrophoblast, 2006, pp.169, 774~783
154. Zhai D, "Maternal exposure to moderate ambient carbon monoxide is associated with decreased risk of preeclampsia", Am J Obstet Gynecol, 207, pp.57~ (2012)
155. Motterlini R, "Therapeutic applications of carbon monoxide-releasing molecules", Expert Opin Investig Drugs, 14, pp.1305~1318 (2005)
156. Foresti R, "Use of carbon monoxide as a therapeutic agent: promises and challenges", Intensive Care Med, 34, pp.649~658 (2008)
157. Motterlini R, "CORM-A1: a new pharmacologically active carbon monoxide-releasing molecule", FASEB J, 19, pp.284~286 (2005)
158. Kretschmer R, "Dicarbonyl-bis(cysteamine)iron(II): a light induced carbon monoxide releasing molecule based on iron (CORM-S1)", J Inorg Biochem, 105, pp.6~9 (2011)
159. Hasegawa U, "Carbon monoxide-releasing micelles for immunotherapy", J Am Chem Soc, 132, pp.18273~18280 (2010)
160. Motterlini R, "Vasorelaxing effects and inhibition of nitric oxide in macrophages by new iron-containing carbon monoxide-releasing molecules (CO-RMs)", Pharmacol Res, 68, pp.108~117 (2013)
161. Foresti R, "Vasoactive properties of CORM-3, a novel water-soluble carbon monoxidereleasing molecule", Br J Pharmacol, 142, pp.453~460 (2004)
162. Sawle P, "Carbon monoxide-releasing molecules (CO-RMs) attenuate the inflammatory response elicited by lipopolysaccharide in RAW264.7 murine macrophages", Br J Pharmacol, 145, pp.800~810 (2005)
163. Sun B, "Preconditioning of carbon monoxide releasing molecule-derived CO attenuates LPS-induced activation of HUVEC", Int J Biol Sci, 4, pp.270~278 (2008)
164. Sun B, "Role of CO-releasing molecules liberated CO in attenuating leukocytes sequestration and inf lammatory responses in the lung of thermally injured mice", J Surg Res, 139, pp.128~135 (2007)
165. Cepinskas G, "Carbon monoxide liberated from carbon monoxide-releasing molecule CORM-2 attenuates inflammation in the liver of septic mice", Am J Physiol Gastrointest Liver Physiol, 294, pp.184~191 (2008)
166. Mizuguchi S, "CORM-3- derived CO modulates polymorphonuclear leukocyte migration across the vascular endothelium by reducing levels of cell surface-bound elastase", Am J Physiol Heart Circ Physiol, 297, pp.920~929 (2009)
167. Lancel S, "Carbon monoxide rescues mice from lethal sepsis by supporting mitochondrial energetic metabolism and activating mitochondrial biogenesis", J Pharmacol Exp Ther, 329, pp.641~648 (2009)
168. Musameh MD, "Improved myocardial function after cold storage with preservation solution supplemented with a carbon monoxide-releasing molecule (CORM-3)", J Heart Lung Transplant, 26, pp.1192~1198 (2007)
169. Mayr FB, "Effects of carbon monoxide inhalation during experimental endotoxemia in humans", Am J Respir Crit Care Med, 171, pp.354~360 (2005)
170. Bathoorn E, "Anti-inf lammatory effects of inhaled carbon monoxide in patients with COPD: a pilot study", Eur Respir J, 30, pp.1131~1137 (2007)

관련 논문AI추천